Pesquisa | BVS Educação Profissional em Saúde

1.

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.

Wilkins, Lamont J; Tosoian, Jeffrey J; Reichard, Chad A; Sundi, Debasish; Ranasinghe, Weranja; Alam, Ridwan; Schwen, Zeyad; Reddy, Chandana; Allaf, Mohammed; Davis, John W; Chapin, Brian F; Ross, Ashley E; Klein, Eric A; Nyame, Yaw A.

Cancer ; 127(9): 1425-1431, 2021 05 01.

Artigo em Inglês | MEDLINE | ID: mdl-33721334

2.

Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities.

Shankar, Prasad R; Ellimoottil, Chad; George, Arvin K; Hadj-Moussa, Miriam; Modi, Parth K; Salami, Simpa; Tosoian, Jeffrey J; Wei, John T; Davenport, Matthew S.

J Urol ; 206(6): 1403-1410, 2021 12.

Artigo em Inglês | MEDLINE | ID: mdl-34288719

3.

Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

Tosoian, Jeffrey J; Trock, Bruce J; Morgan, Todd M; Salami, Simpa S; Tomlins, Scott A; Spratt, Daniel E; Siddiqui, Javed; Kunju, Lakshmi P; Botbyl, Rachel; Chopra, Zoey; Pandian, Balaji; Eyrich, Nicholas W; Longton, Gary; Zheng, Yingye; Palapattu, Ganesh S; Wei, John T; Niknafs, Yashar S; Chinnaiyan, Arul M.

J Urol ; 205(3): 732-739, 2021 03.

Artigo em Inglês | MEDLINE | ID: mdl-33080150

4.

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

Ranasinghe, Weranja; Reichard, Chad A; Nyame, Yaw A; Sundi, Debasish; Tosoian, Jeffrey J; Wilkins, Lamont; Alam, Ridwan; Achim, Mary F; Wang, Xuemei; Stephenson, Andrew J; Klein, Eric A; Ross, Ashley E; Allaf, Mohamad E; Davis, John W; Chapin, Brian F.

J Urol ; 204(4): 748-753, 2020 10.

Artigo em Inglês | MEDLINE | ID: mdl-32259468

5.

Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.

Schwen, Zeyad R; Mamawala, Mufaddal; Tosoian, Jeffrey J; Druskin, Sasha C; Ross, Ashley E; Sokoll, Lori J; Epstein, Jonathan I; Carter, Herbert Ballentine; Gorin, Michael A; Pavlovich, Christian P.

BJU Int ; 126(3): 373-378, 2020 09.

Artigo em Inglês | MEDLINE | ID: mdl-32367635

6.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Sundi, Debasish; Tosoian, Jeffrey J; Nyame, Yaw A; Alam, Ridwan; Achim, Mary; Reichard, Chad A; Li, Jianbo; Wilkins, Lamont; Schwen, Zeyad; Han, Misop; Davis, John W; Klein, Eric A; Schaeffer, Edward M; Stephenson, Andrew J; Ross, Ashley E; Chapin, Brian F.

Cancer ; 125(3): 391-397, 2019 02 01.

Artigo em Inglês | MEDLINE | ID: mdl-30423193

7.

Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time.

Tosoian, Jeffrey J; Yu, Alice; Brisbane, Wayne G.

J Urol ; 211(2): 317-319, 2024 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-38010955

8.

Editorial Comment.

Robinson, Hunter S; Cole, Matthew W; Tosoian, Jeffrey J.

J Urol ; 211(3): 413, 2024 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-38198588

9.

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.

Druskin, Sasha C; Mamawala, Mufaddal; Tosoian, Jeffrey J; Epstein, Jonathan I; Pavlovich, Christian P; Carter, H Ballentine; Trock, Bruce J.

J Urol ; 201(1): 98-104, 2019 01.

Artigo em Inglês | MEDLINE | ID: mdl-30114397

10.

Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.

Faisal, Farzana A; Tosoian, Jeffrey J; Han, Misop; Macura, Katarzyna J; Pavlovich, Christian P; Lotan, Tamara L.

J Urol ; 201(5): 937-942, 2019 05.

Artigo em Inglês | MEDLINE | ID: mdl-30414957

11.

Tissue-based genomics: which test and when.

Vince, Randy A; Tosoian, Jeffrey J; Jackson, William C; Spratt, Daniel E; Morgan, Todd M.

Curr Opin Urol ; 29(6): 598-604, 2019 11.

Artigo em Inglês | MEDLINE | ID: mdl-31584886

12.

A Pragmatic Approach to Prostate Cancer Screening.

Tosoian, Jeffrey J; Penson, David F; Chinnaiyan, Arul M.

JAMA ; 331(17): 1448-1450, 2024 05 07.

Artigo em Inglês | MEDLINE | ID: mdl-38581253

13.

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

Kaur, Harsimar B; Guedes, Liana B; Lu, Jiayun; Maldonado, Laneisha; Reitz, Logan; Barber, John R; De Marzo, Angelo M; Tosoian, Jeffrey J; Tomlins, Scott A; Schaeffer, Edward M; Joshu, Corinne E; Sfanos, Karen S; Lotan, Tamara L.

Mod Pathol ; 31(10): 1539-1552, 2018 10.

Artigo em Inglês | MEDLINE | ID: mdl-29849114

14.

Point-Counterpoint: Clinical Pragmatism Should Prevail Over Biological Orthodoxy: "Pro" Perspective.

Penson, David F; Tosoian, Jeffrey J.

J Urol ; 210(1): 26-27, 2023 07.

Artigo em Inglês | MEDLINE | ID: mdl-37126312

15.

National Trends in the Practice of Active Surveillance.

Akinsola, Olutiwa A; Ellis, Taryn A; Tosoian, Jeffrey J.

J Urol ; 209(4): 659-660, 2023 04.

Artigo em Inglês | MEDLINE | ID: mdl-36756801

16.

Editorial Comment.

Robinson, Hunter S; Samora, Nathan L; Tosoian, Jeffrey J.

J Urol ; 210(1): 106-107, 2023 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-37102722

17.

Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.

Tosoian, Jeffrey J; Mamawala, Mufaddal; Patel, Hiten D; Alam, Ridwan; Epstein, Jonathan I; Ross, Ashley E; Carter, H Ballentine.

J Urol ; 199(4): 954-960, 2018 04.

Artigo em Inglês | MEDLINE | ID: mdl-29074222

18.

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.

Patel, Hiten D; Gupta, Mohit; Tosoian, Jeffrey J; Carter, H Ballentine; Partin, Alan W; Epstein, Jonathan I.

J Urol ; 200(5): 1068-1074, 2018 11.

Artigo em Inglês | MEDLINE | ID: mdl-29673946

19.

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.

Druskin, Sasha C; Tosoian, Jeffrey J; Young, Allen; Collica, Sarah; Srivastava, Arnav; Ghabili, Kamyar; Macura, Katarzyna J; Carter, H Ballentine; Partin, Alan W; Sokoll, Lori J; Ross, Ashley E; Pavlovich, Christian P.

BJU Int ; 121(4): 619-626, 2018 04.

Artigo em Inglês | MEDLINE | ID: mdl-29232037

20.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.

Kishan, Amar U; Cook, Ryan R; Ciezki, Jay P; Ross, Ashley E; Pomerantz, Mark M; Nguyen, Paul L; Shaikh, Talha; Tran, Phuoc T; Sandler, Kiri A; Stock, Richard G; Merrick, Gregory S; Demanes, D Jeffrey; Spratt, Daniel E; Abu-Isa, Eyad I; Wedde, Trude B; Lilleby, Wolfgang; Krauss, Daniel J; Shaw, Grace K; Alam, Ridwan; Reddy, Chandana A; Stephenson, Andrew J; Klein, Eric A; Song, Daniel Y; Tosoian, Jeffrey J; Hegde, John V; Yoo, Sun Mi; Fiano, Ryan; D'Amico, Anthony V; Nickols, Nicholas G; Aronson, William J; Sadeghi, Ahmad; Greco, Stephen; Deville, Curtiland; McNutt, Todd; DeWeese, Theodore L; Reiter, Robert E; Said, Johnathan W; Steinberg, Michael L; Horwitz, Eric M; Kupelian, Patrick A; King, Christopher R.

JAMA ; 319(9): 896-905, 2018 03 06.

Artigo em Inglês | MEDLINE | ID: mdl-29509865

BVS Educação Profissional em Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.

Testing-Related Health Impact of Transrectal and Transperineal Prostate Biopsy as Assessed by Health Utilities.

Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach.

Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.

Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance.

Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.

Point of View: Innovation and Progress for Screening and Management of Localized Prostate Cancer: What an Exciting Time.

Editorial Comment.

Older Age Predicts Biopsy and Radical Prostatectomy Grade Reclassification to Aggressive Prostate Cancer in Men on Active Surveillance.

Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.

Tissue-based genomics: which test and when.

A Pragmatic Approach to Prostate Cancer Screening.

Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer.

Point-Counterpoint: Clinical Pragmatism Should Prevail Over Biological Orthodoxy: "Pro" Perspective.

National Trends in the Practice of Active Surveillance.

Editorial Comment.

Tumor Volume on Biopsy of Low Risk Prostate Cancer Managed with Active Surveillance.

Subtyping the Risk of Intermediate Risk Prostate Cancer for Active Surveillance Based on Adverse Pathology at Radical Prostatectomy.

Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.

Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.